|QIAGEN Bioinformatics Continues to Set the Standard With Hereditary Disease Solution|
|QIAGEN has two milestones in its delivery of solutions for clinical analysis and interpretation of hereditary diseases ...|
|Aerie Pharmaceuticals Announces Four New Abstracts to be Presented at the American Glaucoma Society 26th Annual Meeting Next Week|
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the ...
|ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics|
ProBioGen, a leading specialist for contract development and manufac...
|EMA/CHMP Adopts Positive Opinion for ITM´s EndolucinBeta|
|ITM Isotopen Technologien München AG, a specialized radiopharmaceutical company, tod...|
|Global Biobanking Market 2016-2020 - Analysis|
The market research analyst predicts the global biobanking market to grow steadily at a CAGR of approximately 8% durin...
|Global Market Study on Next-Generation Antibody Therapeutics 2015|
The global next-generation antibody therapeutics market is projected to be valued at US$ 2,250.0 Mn by the end of 2015...